TY  - BOOK
AU  - Lautenschlager,Irmeli
TI  - Cytomegalovirus infections: risk factors, causes and management 
T2  - Allergies and Infectious Diseases
SN  - 9781619422322
PY  - 2012///]
CY  - New York
PB  - Nova Biomedical, Nova Science Publishers, Inc.
KW  - Cytomegalovirus infections
N1  - Includes bibliographical references and index; ""CYTOMEGALOVIRUS INFECTIONS ""; ""CYTOMEGALOVIRUS INFECTIONS ""; ""Contents""; ""Preface""; ""Management of Human Cytomegalovirus Infection in Pregnancy""; ""Abstract""; ""1. Introduction""; ""2. Diagnosis of HCMV Infection""; ""2.1. Primary Infection""; ""2.2. Recurrent Infection""; ""3. Maternal Prognostic Markers of In Utero Transmission""; ""4. Invasive Procedures for Prenatal Diagnosis""; ""4.1. Amniocentesis""; ""4.2. Cordocentesis""; ""5. Fetal Prognostic Markers of Congenital Disease""; ""6. Fetal Imaging Techniques""; ""6.1. Ultrasound""; ""6.2. Magnetic Resonance Imaging""; ""7. Therapeutic Interventions in Pregnancy""""8. Counseling""; ""Conclusion""; ""Acknowledgments""; ""References""; ""CMV and Male Infertility""; ""Abstract""; ""Introduction""; ""Viruses and Human Semen""; ""Cytomegalovirus (CMV)""; ""Conclusion""; ""References""; ""Cytomegalovirus and the Cognitive Immunity: An Old Married Couple for the Best and the Worst""; ""Abstract""; ""Abbreviations""; ""Introduction""; ""A. Effect of the Immunity on CMV Ecology""; ""B. CMV Infection Effects on the Immune Status""; ""CMV May Influence the Quality of the Immune System""; ""Chronic Pro-Inflammatory Effect and Ageing""""CMV Participates in Senescence of the Immune System Itself""; ""CMV Induces the Emergence of Unconventional Phenotypes""; ""CMV Infection and Lymphoproliferative Disorders""; ""Conclusion""; ""References""; ""Human Cytomegalovirus Infection: Risk Factors, Diagnosis, and Impact on Immunity and Health""; ""Abstract""; ""Introduction""; ""Risk Factors for HCMV Infection and Reactivation""; ""Diagnosis""; ""Impact on Immunity and Health""; ""Conclusion""; ""Acknowledgment""; ""References""; ""Immunity to Human Cytomegalovirus""; ""Abstract""; ""Introduction""""Immune Response to HCMV Infection""; ""Age-Related HCMV Immunity""; ""HCMV Infection in Immunocompromised Individuals""; ""a) HCMV and Primary Immunodeficiences""; ""b) HCMV in HIV-Positive Individuals""; ""c) HCMV and Transplantation""; ""Immunologic Monitoring for HCMV""; ""References""; ""Antiviral and Vaccine Strategies against Cytomegalovirus: Current Therapies and Future Directions""; ""Abstract""; ""1. Introduction""; ""1.1. CMV Disease""; ""1.2. Virus Structure""; ""2. CMV Antivirals""; ""2.1. CMV Antiviral Ganciclovir and Prodrug""; ""2.2. Other Licensed CMV Antivirals""""3. Improving on Current Antivirals and Development of New Antivirals""; ""3.1. Beyond Cidofovir""; ""3.2. Methylenecyclopropane Nucleosides""; ""3.3. Maribavir""; ""3.4. Other UL97 mediated CMV Antivirals""; ""3.5. CMV DNA Terminase Complex and Antivirals""; ""3.6. CMV Antivirals and High Throughput Screening""; ""3.7. RNAi and CMV Antiviral Therapy""; ""3.8. Peptide Based CMV Antivirals""; ""3.9. Thymidine Kinase Antivirals and CMV""; ""3.10. CMV Hyper-Immune Globulin Therapy and Congenital Infection""; ""3.11. CMV and Off Label Drug Therapy""
UR  - https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=540894
ER  -